Date | Analyst | Company | Last | Target | Call | Valuation |
06/28/21 | Amfrasers | Hyphens Pharma | 0.315 | 0.43 | Buy | PER17x FY22 |
08/27/21 | SAC Capital | Hyphens Pharma | 0.31 | 0.37 | Buy | PER17.5x FY21 |
11/22/21 | Phillip | Hyphens Pharma | 0.3 | 0.345 | Accumulate | DCF |
01/07/22 | CIMB | Hyphens Pharma | 0.295 | 0.36 | Add | DCF, PER13.5x FY22 |
04/04/22 | Amfrasers | Hyphens Pharma | 0.29 | 0.38 | Outperform | PER15x FY22 |
04/07/22 | SAC Capital | Hyphens Pharma | 0.3 | 0.4 | Buy | |
05/13/22 | Lim & Tan | Hyphens Pharma | 0.28 | 0.37 | Buy | |
05/20/22 | CIMB | Hyphens Pharma | 0.28 | 0.36 | Add | |
05/20/22 | SAC Capital | Hyphens Pharma | 0.28 | 0.4 | Buy | |
06/06/22 | Phillip | Hyphens Pharma | 0.295 | 0.43 | Buy | DCF |
08/18/22 | CIMB | Hyphens Pharma | 0.315 | 0.39 | Add | DCF |
08/29/22 | Phillip | Hyphens Pharma | 0.31 | 0.43 | Buy | DCF |
Saturday, October 8, 2022
Hyphens Pharma - Stock calls
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment